Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1999 1
2002 1
2005 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.
Fucà G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M, Chao J, Klempner SJ, Emmett M, Jayachandran P, Bergamo F, García MD, Mazzoli G, Provenzano L, Colle R, Svrcek M, Ambrosini M, Randon G, Shah AT, Salati M, Fenocchio E, Salvatore L, Chida K, Kawazoe A, Conca V, Curigliano G, Corti F, Cremolini C, Overman M, Andre T, Pietrantonio F. Fucà G, et al. Among authors: mazzoli g. J Immunother Cancer. 2022 Feb;10(2):e004001. doi: 10.1136/jitc-2021-004001. J Immunother Cancer. 2022. PMID: 35110358 Free PMC article.
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
Marmorino F, Prisciandaro M, Giordano M, Ortolan E, Crucitta S, Manca P, Antoniotti C, Valenti MM, Danesi R, Conca V, Mazzoli G, Boccaccino A, Carullo M, Martinetti A, Sottotetti E, Masi G, Sposito C, Zaffaroni N, Milione M, Fontanini G, Del Re M, Pietrantonio F, Cremolini C. Marmorino F, et al. Among authors: mazzoli g. JCO Precis Oncol. 2022 Nov;6:e2200244. doi: 10.1200/PO.22.00244. JCO Precis Oncol. 2022. PMID: 36356286
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
Nasca V, Barretta F, Corti F, Lonardi S, Niger M, Elez ME, Fakih M, Jayachandran P, Shah AT, Salati M, Fenocchio E, Salvatore L, Cremolini C, Ros J, Ambrosini M, Mazzoli G, Intini R, Overman MJ, Miceli R, Pietrantonio F. Nasca V, et al. Among authors: mazzoli g. J Immunother Cancer. 2023 Jan;11(1):e005493. doi: 10.1136/jitc-2022-005493. J Immunother Cancer. 2023. PMID: 36593068 Free PMC article.
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors.
Manca P, Corti F, Intini R, Mazzoli G, Miceli R, Germani MM, Bergamo F, Ambrosini M, Cristarella E, Cerantola R, Boccaccio C, Ricagno G, Ghelardi F, Randon G, Leoncini G, Milione M, Fassan M, Cremolini C, Lonardi S, Pietrantonio F. Manca P, et al. Among authors: mazzoli g. Eur J Cancer. 2023 Jul;187:15-24. doi: 10.1016/j.ejca.2023.03.029. Epub 2023 Mar 31. Eur J Cancer. 2023. PMID: 37099945
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Ghelardi F, Raimondi A, Morano F, Randon G, Pannone A, Guaglio M, Mazzoli G, Nasca V, Milione M, Leoncini G, Sabella G, Greco GF, Lampis BR, Galassi M, Delfanti S, Nannini M, Intini R, Baratti D, Di Bartolomeo M, Deraco M, Pietrantonio F. Ghelardi F, et al. Among authors: mazzoli g. Clin Colorectal Cancer. 2023 Dec;22(4):450-456.e1. doi: 10.1016/j.clcc.2023.08.005. Epub 2023 Aug 11. Clin Colorectal Cancer. 2023. PMID: 37657955
Contrasting Fake News in Oncology: The First Declaration of Good Communication.
Berardi R, Papa R, Scandali VM, Torniai M, Blasi M, Brusa A, Elisei F, Gregori GL, Laurenzi G, Marinelli L, Marinelli M, Mazzoli G, Volpini F, Caporossi M. Berardi R, et al. Among authors: mazzoli g. JCO Glob Oncol. 2021 May;7:740-746. doi: 10.1200/GO.21.00003. JCO Glob Oncol. 2021. PMID: 34019461 Free PMC article.
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer.
Mazzoli G, Cohen R, Lonardi S, Corti F, Elez E, Fakih M, Jayachandran P, Colle R, Shah AT, Salati M, Fenocchio E, Salvatore L, Ambrosini M, Ros J, Intini R, Cremolini C, Overman MJ, André T, Pietrantonio F. Mazzoli G, et al. Eur J Cancer. 2022 Sep;172:171-181. doi: 10.1016/j.ejca.2022.05.044. Epub 2022 Jun 28. Eur J Cancer. 2022. PMID: 35777274
12 results